BG105549A - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents

Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Info

Publication number
BG105549A
BG105549A BG105549A BG10554901A BG105549A BG 105549 A BG105549 A BG 105549A BG 105549 A BG105549 A BG 105549A BG 10554901 A BG10554901 A BG 10554901A BG 105549 A BG105549 A BG 105549A
Authority
BG
Bulgaria
Prior art keywords
nervous system
central nervous
treating diseases
substituted
azabicycloalkane derivatives
Prior art date
Application number
BG105549A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerd Steiner
Rainer Munschauer
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschedorf
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG105549A publication Critical patent/BG105549A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG105549A 1998-11-24 2001-05-30 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system BG105549A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (1)

Publication Number Publication Date
BG105549A true BG105549A (en) 2001-12-29

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105549A BG105549A (en) 1998-11-24 2001-05-30 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Country Status (21)

Country Link
EP (1) EP1133293A1 (no)
JP (1) JP2002530333A (no)
KR (1) KR20010080535A (no)
CN (1) CN1328455A (no)
AR (1) AR021502A1 (no)
AU (1) AU1775300A (no)
BG (1) BG105549A (no)
BR (1) BR9915589A (no)
CA (1) CA2352526A1 (no)
CZ (1) CZ20011796A3 (no)
DE (1) DE19854147A1 (no)
HK (1) HK1040933A1 (no)
HR (1) HRP20010472A2 (no)
HU (1) HUP0104416A3 (no)
IL (1) IL143181A0 (no)
NO (1) NO20012538L (no)
PL (1) PL348758A1 (no)
SK (1) SK7112001A3 (no)
TR (1) TR200101476T2 (no)
WO (1) WO2000030639A1 (no)
ZA (1) ZA200103976B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (pt) 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
BR112015016992A8 (pt) * 2013-01-15 2018-01-23 Novartis Ag uso de agonistas do receptor alfa 7 nicotínico de acetilcolina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2352526A1 (en) 2000-06-02
KR20010080535A (ko) 2001-08-22
NO20012538D0 (no) 2001-05-23
HRP20010472A2 (en) 2003-04-30
JP2002530333A (ja) 2002-09-17
DE19854147A1 (de) 2000-05-25
CZ20011796A3 (cs) 2002-05-15
BR9915589A (pt) 2001-08-07
SK7112001A3 (en) 2001-12-03
AU1775300A (en) 2000-06-13
PL348758A1 (en) 2002-06-03
HUP0104416A3 (en) 2002-11-28
ZA200103976B (en) 2002-05-16
TR200101476T2 (tr) 2001-10-22
HK1040933A1 (zh) 2002-06-28
IL143181A0 (en) 2002-04-21
WO2000030639A1 (de) 2000-06-02
AR021502A1 (es) 2002-07-24
HUP0104416A2 (hu) 2002-04-29
EP1133293A1 (de) 2001-09-19
NO20012538L (no) 2001-07-04
CN1328455A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
YU11501A (sh) Derivati 4,4,-biarilpiperidina sa aktivnošću na receptor opijata
BG106586A (en) Pyrazolopyramidines as therapeutic agents
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
MY121047A (en) Bicyclo [2.2.1] heptanes and related compounds
BG101110A (en) Substituted pyrimidine compounds and their application
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
BG105270A (en) Tetrahydropyridoethers
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
BG104356A (en) Compounds based on azabenzimidazole for the modulation of serin/treonin protein kinase function
YU25399A (sh) 6-fenilpiridil-2-amino derivati korisni kao nos inhibitori
IL129592A0 (en) 5-HT1f agonists
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BG103947A (en) Derivatives of 9-oxymerythromycin
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
IL114754A0 (en) Benzimidazole derivatives
BG105710A (en) 5ht1 antagonists for antidepressant therapy
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
IL135634A0 (en) 5-htif agonists
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system